MedTrace Logo

Development of a Neurocognitive Screening Test

NCT02597504 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1600

Last updated 2023-09-29

No results posted yet for this study

Summary

This research study will evaluate a standalone software application and is designed to standardize and validate new neurocognitive screening testing for children aged 6 through 11, and adolescents and adults ages 12 through 75.

The purpose of this study is to evaluate recently developed computerized tasks sensitive to changes in neurocognitive performance after a concussion. These tests were designed to help measure the effects of concussion on cognitive processes (e.g., memory, attention, brain speed) and visual functioning.

Conditions

Interventions

OTHER

Pen and paper neuropsychological test

Will be administered for Construct Validity to determine agreement with Quick Test

DEVICE

Quick Test

Quick Test, computerized test will be administered to all subjects.

Sponsors & Collaborators

  • ImPACT Applications, Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02597504 on ClinicalTrials.gov